Finance

Lists
SEPN:NASDAQ
Septerna Inc
USD 36,38
+0,08%
(+0,030) 1D
USD 36,38
0,00% (0,00)
After hours
Closed: 19 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SEPN...
Open
USD 36,48
High
USD 37,82
Low
USD 36,04
Mkt. cap
1,70 mjd
Avg. vol.
387,83 k
Volume
0,00
52-wk high
USD 51,09
52-wk low
USD 17,55
EPS
-USD 0,54
Shares outstanding
46,68 m
No. of employees
123
Open
USD 36,48
High
USD 37,82
Low
USD 36,04
Mkt. cap
1,70 mjd
Avg. vol.
387,83 k
Volume
0,00
52-wk high
USD 51,09
52-wk low
USD 17,55
EPS
-USD 0,54
Shares outstanding
46,68 m
No. of employees
123
News stories
From web sources and news partners
About Septerna Inc
CEO-
Employees123
Founded2019
HeadquartersSouth San Francisco, Kalifornië, Verenigde State van Amerika
SectorPharmaceutical industry
Websitesepterna.com
Analyst ratings
Based on 9 analysts giving stock ratings to SEPN in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for SEPN in the last 3 months.
Highest
Current USD 36,38
USD 60,00 (+64,93%)
Average
USD 52,88 (+45,35%)
Lowest
USD 46,00 (+26,44%)
Analyst
Recommendation
Action
Price target
Projected
Date
Derek Archila
Wells Fargo
Buy
Maintained
USD 50,00
+37,4%
09/09/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
USD 48,00
+31,9%
08/19/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
USD 46,00
+26,4%
08/16/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
USD 59,00
+62,2%
08/13/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
USD 60,00
+64,9%
08/12/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
08/11/2026
Martin Auster
Raymond James
Buy
Reiterated
USD 49,00
+34,7%
08/11/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
USD 60,00
+64,9%
08/10/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
USD 51,00
+40,2%
08/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
21,50 m
24,12 m
26,52 m
26,75 m
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
24,26 m
31,86 m
29,54 m
35,13 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,12 m
8,28 m
10,29 m
8,45 m
Operating expense
31,38 m
40,14 m
39,82 m
43,58 m
Total operating expenses
31,38 m
40,14 m
39,82 m
43,58 m
Operating income
-9,89 m
-16,02 m
-13,30 m
-16,84 m
Other non operating income
-6,00 k
-41,00 k
-31,00 k
-23,00 k
EBT including unusual items
8,17 m
-10,73 m
-8,30 m
-12,06 m
EBT excluding unusual items
-4,33 m
-10,73 m
-8,30 m
-12,06 m
Income tax expense
-
12,00 k
337,00 k
973,00 k
Effective tax rate
-
-0,11%
-4,06%
-8,07%
Other operating expenses
-
-
-
-
Net income
8,17 m
-10,74 m
-8,64 m
-13,03 m
Net profit margin
38,02%
-44,52%
-32,56%
-48,73%
Earnings per share
-0,10
-0,24
-0,19
-0,29
Interest and investment income
5,56 m
5,34 m
5,03 m
4,80 m
Interest expense
-
-
-
-
Net interest expenses
5,56 m
5,34 m
5,03 m
4,80 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,48 m
-15,62 m
-12,88 m
-16,41 m
Gain or loss from assets sale
-12,50 m
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme